Skip to main content

Table 3 The hierarchy of outcomes to be extracted and included in final data synthesis

From: Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis

Outcome

Status

Rank

Explanation

All-cause mortality

Primary

1

Total number of deaths in each study group due to any attributed cause.

Myocardial infarction

Primary

1

Non-fatal or fatal myocardial infarction, or sudden cardiac death

2

Non-fatal or fatal myocardial infarction

3

Fatal myocardial infarction, or sudden cardiac death

4

Non-fatal myocardial infarction only

5

Fatal myocardial infarction only

6

Any other definition of a myocardial infarction-related endpoint

Cardiovascular mortality

Secondary

1

Fatal myocardial infarction, stroke, other cardiovascular disease or sudden death

2

Fatal myocardial infarction, stroke or other cardiovascular disease

3

Fatal myocardial infarction, stroke or sudden death

4

Fatal myocardial infarction or stroke

5

Any other definition of cardiovascular mortality

Stroke

Secondary

1

Non-fatal or fatal stroke, not including transient ischaemic attack

2

Fatal stroke

3

Non-fatal stroke

4

Non-fatal stroke or transient ischaemic attack

5

Non-fatal or fatal stroke or transient ischaemic attack

6

Any other definition of a stroke-related endpoint

Revascularisation

Secondary

1

Any need for unplanned revascularisation

Heart failure

Secondary

1

Management of heart failure, requiring medical attention, hospital attendance or admission

  1. Rank 1 is the preferred outcome definition to be extracted and included in data synthesis. In the event of a study not reporting the first-ranked outcome, and this data not being available from contacting authors and sponsors, the next lowest ranked endpoint reported (or calculable without double-counting) in each study will be included in final data synthesis